Page 58 - P4403.14_V97_YOUROTC NOVEMBER FINAL (PRINT)
P. 58

58  SEXUAL HEALTH











                          Be her pharmacy



                                              answers


                                              guidance



                                              solution



                                              comfort


                                              support





                                                                                                  Save

                                                                                              Up             Off
                                                                                              To 11%
                                                                                                 Trade

                  Numark Brand Support Terms and Conditions apply as per your
                  Numark membership agreement and can be found on NumarkNet
                  https://numarknet.com/about-numark/terms-and-conditions/
                  terms-of-sale/brand-support-terms-and-conditions

                       SCAN FOR
                                                                    UK’s best-selling
                        TRAINING

                                                                        contraceptive pill brands        1

                                                                        Support your pharmacy to help women
                                                                           with their contraceptive needs

                       perrigowomenshealth.co.uk                                  1. IRI data 30.09.2023.


                       ESSENTIAL INFORMATION:
                       PRODUCT INFORMATION: ellaOne® 30 mg film-coated tablet (ulipristal acetate). Refer to the SmPC   INDICATION: Hana 75 microgram film coated tablets contains desogestrel and is indicated for
                       for further information. INDICATION: Emergency contraception (EC) within 120 hours (5 days) of   oral contraception in women of childbearing age to prevent pregnancy. Refer to SmPC for further
                       unprotected sexual intercourse or contraceptive failure. Information about this product, including   product information. Information about this product, including adverse reactions, precautions,
                       adverse reactions, precautions, contra-indications, and method of use can be found at: https://  contra-indications, and method of use can be found at: https://mhraproducts4853.blob.core.
                       mhraproducts4853. blob.core.windows.net/docs/b0731d06d3693ecfbd3c4d15547cba88d0f7de6c   windows.net/docs/ f4e6d09fb70790e19085f23d5723fbe70eca96e8 MARKETING AUTHORISATION
                       MARKETING AUTHORISATION HOLDER: Laboratoire HRA Pharma, 200 avenue de Paris, 92320   HOLDER: Laboratoire HRA Pharma, 200 avenue de Paris, 92320 Chatillon, France. MARKETED IN
                       Châtillon, France. MARKETED IN THE UK BY: HRA Pharma a Perrigo Company, One Embassy Gardens,   THE UK BY: HRA Pharma a Perrigo Company, One Embassy Gardens, Viaduct Gardens, Nine Elms,
                                                                     London SW11 7BW, United Kingdom. LEGAL CATEGORY: P. Additional information and full Product
                       Viaduct Gardens, Nine Elms, London SW11 7BW, United Kingdom LEGAL CATEGORY: P
                                                                     Information is available on request from HRA-UK@cambreg.co.uk
                       Date of last revision of text: October 2023. Unique ID: UK/ELLA/1672   Date of last revision of text: October 2023. Company Reference: UK/HANA/0582
                                       Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
                                          Adverse events should also be reported to HRA Pharma on 0800 917 9548 or email HRA-UK@cambreg.co.uk
                       Date of preparation: December 2023. Code: UK/ELLA/1699.       Buying       Trade    POR
                                                                Product        Size  Price/  RRP  Offer   %   Pip Code
                                                                                     Single        %
                    Be_Her_Trade_A4 Ad_FINAL.indd   1
                                                                                                             01/12/2023   12:58
                    Be_Her_Trade_A4 Ad_FINAL.indd   1           ELLAONE/HANA                                 01/12/2023   12:58
                                                                     EllaOne 30mg   1  £12.67  £34.95  10%  56%  3478708
                                                                   Hana 75 mg 84s  84  £13.02  £21.95  11%  29%  4163192
                                                                    Hana 75mg  28s  28  £5.97  £9.95  10%  28%  4163184





                                                                                                                 15/10/2024   17:12:02
         P4403.14_V97_YOUROTC NOVEMBER FINAL.indd   58                                                           15/10/2024   17:12:02
         P4403.14_V97_YOUROTC NOVEMBER FINAL.indd   58
   53   54   55   56   57   58   59   60   61   62   63